Protection against Recurrent Stroke with Resveratrol: Endothelial Protection

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Clark, Darren ^a,b,c   Tuor, Ursula I ^a,b   Thompson, Roger ^b   Institoris, Adam ^d   Kulynych, Angela ^b   Zhang, Xu ^a   Kinniburgh, David W ^a   Bari, Ferenc ^c   Busija, David W ^e   Barber, Philip A ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESVERATROL; SIRTUIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN SYNTHESIS; RAT; RECURRENT DISEASE; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BODY TEMPERATURE; BRAIN; CELL DEATH; CELL HYPOXIA; CEREBROVASCULAR CIRCULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCOSE; HEART RATE; INFLAMMATION; LIVER; NITROSATION; OXIDATION-REDUCTION; OXYGEN; RATS; RECURRENCE; STILBENES; STRESS, PHYSIOLOGICAL; STROKE; TREATMENT OUTCOME;

EID: 84867638155     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047792     Document Type: Article

References (39)

1. Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, et al. (2005) Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 36: 720-723.
2. Couillard P, Poppe AY, Coutts SB, (2009) Predicting recurrent stroke after minor stroke and transient ischemic attack. Expert Rev Cardiovasc Ther 7: 1273-1281.
3. Qiao M, Zhao Z, Barber PA, Foniok T, Sun S, Tuor UI, (2009) Development of a model of recurrent stroke consisting of a mild transient stroke followed by a second moderate stroke in rats. J Neurosci Methods 184: 244-250.
4. Gidday JM, (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7: 437-448.
5. Sinha K, Chaudhary G, Gupta YK, (2002) Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71: 655-665.
6. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F, (2004) Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40: 138-145.
7. Baur JA, Sinclair DA, (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506.
8. Tsai SK, Hung LM, Fu YT, Cheng H, Nien MW, et al. (2007) Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46: 346-353.
9. Dong W, Li N, Gao D, Zhen H, Zhang X, Li F, (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 48: 709-714.
10. Borriello A, Cucciolla V, Della RF, Galletti P, (2010) Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis 20: 618-625.
11. Morris KC, Lin HW, Thompson JW, Perez-Pinzon MA, (2011) Pathways for ischemic cytoprotection: Role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab 31: 1003-1019.
12. Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, et al. (2009) Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 53 (Suppl 1): S7-15.
13. Chan V, Fenning A, Iyer A, Hoey A, Brown L, (2010) Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats. Curr Pharm Biotechnol 12: 429-436.
14. Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, et al. (2010) Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 23: 192-196.
15. Dal-Pan A, Blanc S, Aujard F, (2010) Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. BMC Physiol 10: 11.
16. Mayers JR, Iliff BW, Swoap SJ, (2009) Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction. FASEB J 23: 1032-1040.
17. Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, et al. (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62: 441-450.
18. Qiao M, Meng S, Foniok T, Tuor UI, (2009) Mild cerebral hypoxia-ischemia produces a sub-acute transient inflammatory response that is less selective and prolonged after a substantial insult. Int J Dev Neurosci 27: 691-700.
19. Del Zoppo GJ, (2010) The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci 1207: 46-49.
20. Rosenberg GA, (2012) Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 32: 1139-1151.
21. Schmitt CA, Heiss EH, Dirsch VM, (2010) Effect of resveratrol on endothelial cell function: Molecular mechanisms. Biofactors 36: 342-349.
22. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, et al. (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159: 993-1002.
23. Shin JA, Lee H, Lim YK, Koh Y, Choi JH, et al. (2010) Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J Neuroimmunol.
24. Aries MJ, Elting JW, De KJ, Kremer BP, Vroomen PC, (2010) Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 41: 2697-2704.
25. Busto R, Dietrich WD, Globus MYT, Baldes I, Scheinberg P, et al. (1987) Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metabol 7: 729-738.
26. Yenari MA, Hemmen TM, (2010) Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke 41: S72-S74.
27. Wang CX, Stroink A, Casto JM, Kattner K, (2009) Hyperthermia exacerbates ischaemic brain injury. Int J Stroke 4: 274-284.
28. Yang Y, Rosenberg GA, (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42: 3323-3328.
29. Kaur J, Tuor UI, Zhao Z, Barber PA (2011) Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly. J Cereb Blood Flow Metab.
30. Gao D, Zhang X, Jiang X, Peng Y, Huang W, et al. (2006) Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 78: 2564-2570.
31. Cheng G, Zhang X, Gao D, Jiang X, Dong W, (2009) Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 451: 105-108.
32. Lin YL, Chang HC, Chen TL, Chang JH, Chiu WT, et al. (2010) Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140: 2187-2192.
33. Chang HC, Chen TG, Tai YT, Chen TL, Chiu WT, et al. (2010) Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab.
34. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, et al. (2009) Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297: H1876-H1881.
35. Ungvari Z, Bagi Z, Feher A, Recchia FA, Sonntag WE, et al. (2010) Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 299: H18-H24.
36. Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, et al. (2007) Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 848: 182-187.
37. Domoki F, Kis B, Gaspar T, Bari F, Busija DW, (2008) Cerebromicrovascular endothelial cells are resistant to L-glutamate. Am J Physiol Regul Integr Comp Physiol 295: R1099-R1108.
38. Kis B, Kaiya H, Nishi R, Deli MA, Abraham CS, et al. (2002) Cerebral endothelial cells are a major source of adrenomedullin. J Neuroendocrinol 14: 283-293.
39. Perriere N, Demeuse P, Garcia E, Regina A, Debray M, et al. (2005) Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 93: 279-289.